[Federal Register Volume 65, Number 4 (Thursday, January 6, 2000)]
[Notices]
[Page 783]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-239]



[[Page 783]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


National Mammography Quality Assurance Advisory Committee; Notice 
of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: National Mammography Quality Assurance Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on January 31, 2000, 9 a.m. 
to 6 p.m.
    Location: Holiday Inn, Walker/Whetstone Rooms, Two Montgomery 
Village Ave., Gaithersburg, MD.
    Contact Person: Charles A. Finder, Center for Devices and 
Radiological Health (HFZ-240), Food and Drug Administration, 1350 
Piccard Dr., Rockville, MD 20850, 301-594-3332, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12397. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will: (1) Discuss the establishment of a 
proposed demonstration project to assess the efficacy of less than 
annual inspections as described in the Mammography Quality Standards 
Reauthorization Act of 1998, and (2) continue the discussion of the 
Mammography Quality Standards Act (the MQSA) compliance guidance. The 
committee will also receive updates on the status of facility 
noncompliance under final regulation inspections, accreditation and 
certification of full field digital mammography, States as 
certification agencies under the MQSA, and Voluntary Stereotactic 
Accreditation Programs. The MQSA compliance guidance documents, which 
are in a question and answer format, are available to the public on the 
Internet at http://www.fda.gov/cdrh/mammography. The guidance is being 
updated continually in response to questions that FDA receives from the 
public. Additional information regarding guidance updates may be 
obtained by calling the Information Line.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by January 10, 
2000. Oral presentations from the public will be scheduled between 
approximately 9:30 a.m. and 10:30 a.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before January 10, 2000, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: December 28, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-239 Filed 1-5-00; 8:45 am]
BILLING CODE 4160-01-F